Table 1 Descriptive statistics.
HC (n = 110) | MDD (n = 110) | BD (n = 110) | SSD (n = 110) | p | |
|---|---|---|---|---|---|
Age | 38.83 (12.21) | 38.35 (11.7) | 39.81 (12.25) | 38.37 (11.71) | 0.783 |
Sex | M = 54 | M = 56 | M = 51 | M = 56 | 0.736 |
F = 56 | F = 54 | F = 59 | F = 54 | ||
TIV | 1529.98 (146.74) | 1520.97 (172.35) | 1539.99 (137.63) | 1542.78 (180.99) | 0.566 |
Age of onset | – | 27 (12.19) | 23.47 (10.37) | 22.51 (9.02) | 0.005a |
In-patient treatment n, (%) | – | 40 (36.36%) | 28 (25.45%) | 48 (43.64%) | 0.012 |
Remission statush | – | A = 65 | A = 69 | A = 75 | 0.371 |
R = 45 | R = 41 | R = 35 | |||
Antidepressant n, (%) | – | 71 (64.55%) | 46 (41.82%) | 32 (29.09%) | <0.001 |
Antipsychotics n, (%) | – | 21 (19.09%) | 50 (45.45%) | 95 (86.36%) | <0.001 |
Lithium n, (%) | – | 2 (1.82%) | 31 (28.18%) | 4 (3.64%) | <0.001 |
Anticonvulsive n, (%) | – | 2 (1.82%) | 36 (32.73%) | 8 (7.27%) | <0.001 |
Comorbidity n, (%) | – | 37 (33.64%) | 46 (41.82%) | 42 (39.09%) | 0.453 |
HAMA | 2.09 (2.61) | 12.69 (8.15) | 9.25 (7.35) | 9.63 (7.37) | <0.001b |
HAM-D | 1.0 (1.6) | 7.65 (5.94) | 6.5 (5.97) | 6.55 (5.78) | <0.001c |
SANS | 0.87 (2.24) | 7.04 (7.52) | 5.34 (7.03) | 12.73 (12.52) | <0.001d |
SAPS | 0.20 (0.71) | 0.38 (1.18) | 2.3 (4.38) | 10.6 (13.26) | <0.001e |
YMRS | 0.47 (1.06) | 1.13 (1.77) | 3.89 (5.94) | 2.99 (5.12) | <0.001f |
GAF | 91.43 (7.4) | 63.89 (13.7) | 62.81(12.75) | 54.93 (12.39) | <0.001g |
